Skip to content

Source filing unavailable

Q3 2020 · —
Revenue$52.00Kno prior Q3 2019 on file+23.8% vs Q2 2020
Net Income-$7.26Mno prior Q3 2019 on fileN/M vs Q2 2020
EPS Diluted-$0.43no prior Q3 2019 on fileN/M vs Q2 2020
Operating Income-$7,711,000—
Operating Cash Flowderived-$7,235,000—
Free Cash Flowderived-$11,537,000—
Margins · derived
Operating margin-14828.8%
Net margin-13965.4%

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

no prior Q3 2019 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Instil Bio, Inc. · CIK 1789769 · Engraved from SEC EDGAR